Malzahn Craig bought RGNX
November 1, 2026 · Form 4 insider transaction
Malzahn Craig bought 27,777 shares of REGENXBIO Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
27,777
Price
$0.00
Total value
N/A
InsiderMalzahn Craig
RoleOfficer
CompanyREGENXBIO Inc. (RGNX)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateNovember 1, 2026
Filing dateNovember 3, 2026
Shares owned after109,737
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 1/3rd of the shares subject to the RSU award shall vest on each of November 1, 2027, November 1, 2028, and November 1, 2029, while the recipient provides continuous service to the Issuer.